273 related articles for article (PubMed ID: 7694638)
1. Few peptides dominate cytotoxic T lymphocyte responses to single and multiple minor histocompatibility antigens.
Yin L; Poirier G; Neth O; Hsuan JJ; Totty NF; Stauss HJ
Int Immunol; 1993 Sep; 5(9):1003-9. PubMed ID: 7694638
[TBL] [Abstract][Full Text] [Related]
2. Dominant and cryptic antigens in the MHC class I restricted T cell response across a complex minor histocompatibility barrier: analysis and mapping by elution of cellular peptides.
Wolpert E; Franksson L; Kärre K
Int Immunol; 1995 Jun; 7(6):919-28. PubMed ID: 7577800
[TBL] [Abstract][Full Text] [Related]
3. Presentation of a horse cytochrome c peptide by multiple H-2b class I major histocompatibility complex (MHC) molecules to C57BL/6- and bm1-derived cytotoxic T lymphocytes: presence of a single MHC anchor residue may confer efficient peptide-specific CTL recognition.
Sheil JM; Schell TD; Shepherd SE; Klimo GF; Kioschos JM; Paterson Y
Eur J Immunol; 1994 Sep; 24(9):2141-9. PubMed ID: 7522163
[TBL] [Abstract][Full Text] [Related]
4. On the mechanisms of immunodominance in cytotoxic T lymphocyte responses to minor histocompatibility antigens.
Pion S; Fontaine P; Desaulniers M; Jutras J; Filep JG; Perreault C
Eur J Immunol; 1997 Feb; 27(2):421-30. PubMed ID: 9045913
[TBL] [Abstract][Full Text] [Related]
5. T lymphocyte responses to multiple minor histocompatibility antigens generate both self-major histocompatibility complex-restricted and cross-reactive cytotoxic T lymphocytes.
Tremblay N; Fontaine P; Perreault C
Transplantation; 1994 Jul; 58(1):59-67. PubMed ID: 8036709
[TBL] [Abstract][Full Text] [Related]
6. Immunodominance in the CTL response against minor histocompatibility antigens: interference between responding T cells, rather than with presentation of epitopes.
Wolpert EZ; Grufman P; Sandberg JK; Tegnesjö A; Kärre K
J Immunol; 1998 Nov; 161(9):4499-505. PubMed ID: 9794374
[TBL] [Abstract][Full Text] [Related]
7. Immunization with dendritic cells breaks immunodominance in CTL responses against minor histocompatibility and synthetic peptide antigens.
Grufman P; Sandberg JK; Wolpert EZ; Kärre K
J Leukoc Biol; 1999 Aug; 66(2):268-71. PubMed ID: 10449165
[TBL] [Abstract][Full Text] [Related]
8. Induction and characterization of minor histocompatibility antigens. Specific primary cytotoxic T lymphocyte responses in vitro.
Ando K; Nakashima I; Nagase F; Isobe K; Kawashima K; Hasegawa Y; Yoshida T; Iwamoto T; Hasegawa T; Muro Y
J Immunol; 1988 Feb; 140(3):723-9. PubMed ID: 2448374
[TBL] [Abstract][Full Text] [Related]
9. Limitations of predictive motifs revealed by cytotoxic T lymphocyte epitope mapping of the human papilloma virus E7 protein.
Sadovnikova E; Zhu X; Collins SM; Zhou J; Vousden K; Crawford L; Beverley P; Stauss HJ
Int Immunol; 1994 Feb; 6(2):289-96. PubMed ID: 7512375
[TBL] [Abstract][Full Text] [Related]
10. Identification of Meth A sarcoma-derived class I major histocompatibility complex-associated peptides recognized by a specific CD8+ cytotoxic T lymphocyte.
Frassanito MA; Mayordomo JI; DeLeo RM; Storkus WJ; Lotze MT; DeLeo AB
Cancer Res; 1995 Jan; 55(1):124-8. PubMed ID: 7528638
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic T lymphocyte responses to minor H-43 alloantigens in H-43a and H-43b mice. Both anti-H-43b and anti-H-43a CTL activities are generated exclusively in the context of the same H-2Kb restriction element.
Ishikawa H; Kusakabe A; Hayakawa J; Hino T
J Immunol; 1988 Nov; 141(9):2918-23. PubMed ID: 3139769
[TBL] [Abstract][Full Text] [Related]
12. An immunodominant epitope present in multiple class I MHC molecules and recognized by cytotoxic T lymphocytes.
Mann DW; McLaughlin-Taylor E; Wallace RB; Forman J
J Exp Med; 1988 Jul; 168(1):307-24. PubMed ID: 2456370
[TBL] [Abstract][Full Text] [Related]
13. The target minor H antigen for F1 cytotoxic T lymphocytes induced by Igh-congenic parental spleen cells is coded for by gene linked to H-2.
Ishikawa H; Kubota E; Suzuki H; Saito K
J Immunol; 1985 May; 134(5):2953-9. PubMed ID: 2580009
[TBL] [Abstract][Full Text] [Related]
14. Immunodominant minor histocompatibility antigen peptides presented by H2Db molecules.
Nevala WK; Wettstein PJ
Transplantation; 1997 Nov; 64(9):1323-30. PubMed ID: 9371675
[TBL] [Abstract][Full Text] [Related]
15. Beta 2-microglobulin independent presentation of exogenously added foreign peptide and endogenous self-epitope by MHC class I alpha-chain to a cross-reactive CD8+ CTL clone.
Zügel U; Schoel B; Kaufmann SH
J Immunol; 1994 Nov; 153(9):4070-80. PubMed ID: 7523514
[TBL] [Abstract][Full Text] [Related]
16. Identification of classical minor histocompatibility antigen as cell-derived peptide.
Wallny HJ; Rammensee HG
Nature; 1990 Jan; 343(6255):275-8. PubMed ID: 1689009
[TBL] [Abstract][Full Text] [Related]
17. Reduced diversity of CTLs specific for multiple minor histocompatibility antigens relative to allograft rejection in vivo.
Nevala WK; Paul C; Wettstein PJ
J Immunol; 1997 Feb; 158(3):1102-7. PubMed ID: 9013948
[TBL] [Abstract][Full Text] [Related]
18. Differential binding of a minor histocompatibility antigen peptide to H-2 class I molecules correlates with immune responsiveness.
Wettstein PJ; van Bleek GM; Nathenson SG
J Immunol; 1993 Apr; 150(7):2753-60. PubMed ID: 7681080
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic T lymphocyte escape variants, induced mutations, and synthetic peptides define a dominant H-2Kb-restricted determinant in simian virus 40 tumor antigen.
Mylin LM; Deckhut AM; Bonneau RH; Kierstead TD; Tevethia MJ; Simmons DT; Tevethi SS
Virology; 1995 Apr; 208(1):159-72. PubMed ID: 11831696
[TBL] [Abstract][Full Text] [Related]
20. Immunodominant minor histocompatibility antigen peptides recognized by cytolytic T lymphocytes primed by indirect presentation.
Nevala WK; Paul C; Wettstein PJ
Transplantation; 1998 Feb; 65(4):559-69. PubMed ID: 9500633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]